Two Sigma Investments LP Trims Stock Position in Pediatrix Medical Group, Inc. (NYSE:MD)

Two Sigma Investments LP decreased its position in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 21.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 85,943 shares of the company's stock after selling 23,482 shares during the period. Two Sigma Investments LP owned approximately 0.10% of Pediatrix Medical Group worth $1,128,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in MD. Vanguard Group Inc. increased its position in shares of Pediatrix Medical Group by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 10,812,611 shares of the company's stock valued at $141,861,000 after purchasing an additional 113,976 shares during the last quarter. Boston Partners raised its stake in Pediatrix Medical Group by 25.2% in the fourth quarter. Boston Partners now owns 1,956,353 shares of the company's stock worth $25,922,000 after buying an additional 393,600 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Pediatrix Medical Group by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 1,947,796 shares of the company's stock valued at $25,562,000 after buying an additional 11,045 shares in the last quarter. American Century Companies Inc. raised its stake in Pediatrix Medical Group by 628.2% in the fourth quarter. American Century Companies Inc. now owns 1,739,323 shares of the company's stock valued at $22,820,000 after buying an additional 1,500,485 shares during the last quarter. Finally, Northern Trust Corp grew its holdings in shares of Pediatrix Medical Group by 18.0% during the fourth quarter. Northern Trust Corp now owns 966,347 shares of the company's stock valued at $12,678,000 after buying an additional 147,522 shares during the last quarter. Institutional investors own 97.71% of the company's stock.

Wall Street Analyst Weigh In

MD has been the topic of several analyst reports. Truist Financial dropped their target price on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a report on Friday, April 11th. UBS Group dropped their price target on Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating for the company in a research report on Monday, May 12th. Finally, Macquarie upped their price objective on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a report on Thursday, May 8th. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $16.67.

Pediatrix Medical Group Stock Up 0.3%

Shares of NYSE:MD traded up $0.04 during trading on Monday, hitting $14.13. The company's stock had a trading volume of 876,357 shares, compared to its average volume of 826,778. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $17.67. The company has a market capitalization of $1.21 billion, a PE ratio of -11.78, a P/E/G ratio of 1.74 and a beta of 1.27. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60. The business has a 50 day moving average price of $13.65 and a two-hundred day moving average price of $14.00.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.08. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The business had revenue of $458.36 million during the quarter, compared to analysts' expectations of $451.44 million. During the same period in the prior year, the firm posted $0.20 EPS. The business's quarterly revenue was down 7.4% compared to the same quarter last year. As a group, research analysts expect that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.